Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay

Priyanka Iyer, Ramona Dadu, Anna Barque, Cleslei Fernando Zanelli, Xingyu Zheng, Huimin Jiang, P. Sean Walsh, Yangyang Hao, Jing Huang, Joshua Klopper, Richard T. Kloos, Maria E. CabanillasThe Journal of Clinical Endocrinology & Metabolism 2024 · DOI

Abstract

The analytical robustness and reproducibility of the Afirma TERT test support its routine clinical use among thyroid nodules with indeterminate cytology that are Afirma Genomic Sequencing Classifier suspicious or among Bethesda V/VI nodules.
BibTeX
@article{iyer2024analytical,
  author = {Priyanka Iyer and Ramona Dadu and Anna Barque and Cleslei Fernando Zanelli and Xingyu Zheng and Huimin Jiang and P. Sean Walsh and Yangyang Hao and Jing Huang and Joshua Klopper and Richard T. Kloos and Maria E. Cabanillas},
  title = {{Analytical Validation of a Telomerase Reverse Transcriptase (<i>TERT</i>) Promoter Mutation Assay}},
  journal = {The Journal of Clinical Endocrinology \& Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae134},
}

Loading related content...

Figure